CD274 and cancer: As immunotherapy works through the activation of the immune system (and, compared to chemotherapy, does not kill cancer cells directly), any disturbances in the function of immune system might lead to worse treatment outcomes in patients dosed with PD-1/PD-L1 inhibitors.